Covidien plc Buyback
OLI recorded this information on 3/21/2013
Covidien plc announced that its Board of Directors has authorized a new program to purchase up to $3 billion of the Company's ordinary shares from time to time, based on market conditions. This program is in addition to the $2.0 billion share repurchase program announced in August 2011, which currently has approximately $425 million remaining.
Covidien is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Co.'s reportable segments are as follows: Medical Devices, which includes the sales of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products; and U.S. Medical Supplies, which includes the sale of nursing care products, medical surgical, SharpSafety™ and original equipment manufacturer products. Co.'s medical devices are used primarily by hospitals and ambulatory care centers, as well as alternate site healthcare providers, such as physician offices.
Open the COV Page at The Online Investor »
Buy (2.60 out of 4)
(ranked higher than approx. 71% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite